Hematology TimesCancer patients want info about marijuanaSeptember 26, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCancer patients’ complaints about careSeptember 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsNew antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65September 20, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesTeam creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTrials of atezolizumab placed on partial holdSeptember 19, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesApplication for pegfilgrastim biosimilar withdrawnSeptember 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology NewsMost daratumumab infusion reactions occur in first infusionSeptember 14, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesReport details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
Hematology NewsKW-2478 examined as novel add-on therapy for myelomaSeptember 13, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesStudy: Many cancer patients don’t understand clinical trialsSeptember 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesFDA places full, partial holds on durvalumab trialsSeptember 8, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA places partial hold on trials of nivolumab in MMSeptember 8, 2017Multiple Myeloma
Hematology TimesFDA grants orphan designation to product for CMVSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesFDA grants orphan designation to product for GVHDSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesFDA warns about risk of death with pembrolizumab in MMSeptember 1, 2017Multiple Myeloma
